6. パーキンソン病 Parkinson disease Clinical trials / Disease details
臨床試験数 : 2,298 / 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202
Showing 1 to 10 of 11 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05197439 (ClinicalTrials.gov) | April 1, 2022 | 5/1/2022 | Dexmedetomidine Prevents Postoperative Delirium After Deep Brain Stimulation in Patients With Parkinson's Disease DexmedetomidinePrevents Postoperative Delirium After Deep Brain Stimulation in Patients With Parkins ... | Effect of Dexmedetomidine on Postoperative Delirium in Elderly Patients With Parkinson's Disease Undergoing Deep Brain Stimulation: a Randomized Controlled Trial Effect of Dexmedetomidineon Postoperative Delirium in Elderly Patients With Parkinson's Disease Unde ... | Dexmedetomidine;Postoperative Delirium;Deep Brain Stimulation | Drug: Dexmedetomidine;Drug: 0.9% saline | Beijing Tiantan Hospital | NULL | Not yet recruiting | 60 Years | N/A | All | 182 | N/A | China |
2 | ChiCTR2100048680 | 2021-08-01 | 2021-07-12 | The clinical study on the sedative efficacy and wakefulness of dexmedetomidine in Parkinson's disease patients The clinical study on the sedative efficacy and wakefulness of dexmedetomidinein Parkinson's disease ... | The clinical study on the sedative efficacy and wakefulness of dexmedetomidine in Parkinson's disease patients The clinical study on the sedative efficacy and wakefulness of dexmedetomidinein Parkinson's disease ... | Parkinson's disease | Experimental group:An infusion of dexmedetomidine;Control group:None; | The First Affiliated Hospital of University of Science and Technology of China (Southern District Phase 2) The First Affiliated Hospital of University of Science and Technology of China (Southern District Ph ... | NULL | Pending | 35 | 75 | Both | Experimental group:35;Control group:35; | China | |
3 | NCT02982512 (ClinicalTrials.gov) | May 1, 2017 | 28/11/2016 | Dexmedetomidine on Basal Ganglia Neuronal Activity in Parkinson's Disease | Effects of Different Concentrations of Dexmedetomidine on Basal Ganglia Neuronal Activity (Local Field Potentials) in Parkinson's Disease Effects of Different Concentrations of Dexmedetomidineon Basal Ganglia Neuronal Activity (Local Fiel ... | Dexmedetomidine;Deep Brain Stimulation;Parkinson Disease | Drug: Dexmedetomidine | Clinica Universidad de Navarra, Universidad de Navarra | NULL | Unknown status | 18 Years | N/A | All | 12 | Phase 4 | Spain |
4 | ChiCTR-IOR-16010168 | 2016-12-20 | 2016-12-15 | Propofol-remifetanyl vs dexmedetomidine continous infusion for deep brain stimulation implantation | Propofol-remifetanyl vs dexmedetomidine continous infusion for deep brain stimulation implantation | Parkinson's Disease | propofol-remifentanyl group:propofol-remifentany infusion for monitored anesthesia care during awake deep brain stimulation surgery;dexmedetomidine group:dexmedetomidine infusion for monitored anesthesia care during awake deep brain stimulation surgery; propofol-remifentanylgroup:propofol-remifentany infusion for monitored anesthesia care during awake ... | West China Hospital, Sichuan University | NULL | Recruiting | 18 | Both | propofol-remifentanyl group:25;dexmedetomidine group:25; | China | ||
5 | ChiCTR2000037957 | 2016-12-01 | 2020-09-07 | Clinical study of dexmedetomidine on deep brain stimulation in middle-aged and elderly patients with Parkinson's disease Clinical study of dexmedetomidineon deep brain stimulation in middle-aged and elderly patients with ... | Clinical study of dexmedetomidine on deep brain stimulation in middle-aged and elderly patients with Parkinson's disease Clinical study of dexmedetomidineon deep brain stimulation in middle-aged and elderly patients with ... | Deep brain stimulation in patients with Parkinson's disease | Experimental group:conscious sedation with dexmedetomidine;control group:Pump in normal saline; | Shanghai Jing'an District Central Hospital | NULL | Completed | 45 | 75 | Both | Experimental group:27;control group:9; | China | |
6 | EUCTR2016-002680-34-ES (EUCTR) | 20/10/2016 | 05/08/2016 | Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease. Effects of different concentrations of dexmedetomidineon basal ganglia neuronal activity (local fiel ... | Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease. Effects of different concentrations of dexmedetomidineon basal ganglia neuronal activity (local fiel ... | Parkinson's disease MedDRA version: 19.0;Level: LLT;Classification code 10013113;Term: Disease Parkinson's;System Organ Class: 100000004852;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] Parkinson's disease MedDRA version: 19.0;Level: LLT;Classification code 10013113;Term: Disease Parki ... | Trade Name: Dexdor Product Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Other descriptive name: DEXMEDETOMIDINA Trade Name: Dexdor Product Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Other descriptive name: DE ... | Clínica Universidad de Navarra/Universidad de Navarra | NULL | Not Recruiting | Female: yes Male: yes | 12 | Phase 4 | Spain | ||
7 | NCT02256319 (ClinicalTrials.gov) | September 2014 | 30/9/2014 | Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimulators Dexmedetomidinevs Propofol on the Recordings of Deep Brain Activity Measured Through Implanted Stimu ... | Effects of Dexmedetomidine vs Propofol on the Recordings of Deep Brain Activity (Local Field Potentials) Measured Through Implanted Stimulators Effects of Dexmedetomidinevs Propofol on the Recordings of Deep Brain Activity (Local Field Potentia ... | Parkinson's Disease | Drug: Dexmedetomidine;Drug: Propofol | Clinica Universidad de Navarra, Universidad de Navarra | NULL | Completed | 18 Years | N/A | Both | 12 | Phase 4 | Spain |
8 | EUCTR2014-000868-17-ES (EUCTR) | 26/06/2014 | 17/03/2014 | Effect of dexmedetomidine vs propofol on basal ganglia activity (local field potentials) recorded through implanted stimulators Effect of dexmedetomidinevs propofol on basal ganglia activity (local field potentials) recorded thr ... | Effect of dexmedetomidine vs propofol on basal ganglia activity (local field potentials) recorded through implanted stimulators Effect of dexmedetomidinevs propofol on basal ganglia activity (local field potentials) recorded thr ... | Parkinson's disease MedDRA version: 16.1;Level: LLT;Classification code 10013113;Term: Disease Parkinson's;System Organ Class: 100000004852;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03] Parkinson's disease MedDRA version: 16.1;Level: LLT;Classification code 10013113;Term: Disease Parki ... | Trade Name: Dexdor Product Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Other descriptive name: DEXMEDETOMIDINA Trade Name: Propofol-Lipuro Product Name: Propofol-Lipuro INN or Proposed INN: PROPOFOL Other descriptive name: PROPOFOL Trade Name: Dexdor Product Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE Other descriptive name: DE ... | Clínica Universidad de Navarra/Universidad de Navarra | NULL | Not Recruiting | Female: yes Male: yes | Spain | ||||
9 | NCT01789385 (ClinicalTrials.gov) | February 2013 | 2/2/2013 | Anesthesia for Deep Brain Stimulation | Anesthesia for Deep Brain Stimulation for the Treatment of Parkinsons Disease | Parkinsons Disease | Drug: Dexmedetomidine | Diskapi Teaching and Research Hospital | NULL | Completed | 19 Years | 85 Years | Both | 26 | Phase 4 | Turkey |
10 | NCT01721460 (ClinicalTrials.gov) | November 2012 | 30/10/2012 | Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus | Effects of Dexmedetomidine on Neuronal Activity in the Subthalamic Nucleus During Deep Brain Stimulation (DBS) Electrode Implantation Surgery Effects of Dexmedetomidineon Neuronal Activity in the Subthalamic Nucleus During Deep Brain Stimulat ... | Parkinson's Disease;Deep Brain Stimulation Surgery | Drug: Dexmedetomidine | University of Wisconsin, Madison | NULL | Completed | 18 Years | 85 Years | All | 6 | Phase 4 | United States |